Renaissance Technologies LLC Sells 2,209 Shares of Nutex Health Inc. (NASDAQ:NUTX)

Renaissance Technologies LLC decreased its stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 22.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,689 shares of the company's stock after selling 2,209 shares during the period. Renaissance Technologies LLC owned approximately 0.14% of Nutex Health worth $244,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of NUTX. American Century Companies Inc. acquired a new position in shares of Nutex Health during the fourth quarter valued at about $1,362,000. Drive Wealth Management LLC bought a new position in Nutex Health during the fourth quarter valued at about $1,122,000. Essex Investment Management Co. LLC raised its holdings in Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after acquiring an additional 33,024 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in shares of Nutex Health in the 4th quarter worth approximately $672,000. Finally, World Investment Advisors acquired a new stake in shares of Nutex Health during the 4th quarter worth approximately $217,000. Institutional investors own 5.32% of the company's stock.

Insiders Place Their Bets

In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the acquisition, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 38.52% of the company's stock.

Analyst Ratings Changes

Separately, Maxim Group raised their target price on Nutex Health from $75.00 to $100.00 and gave the stock a "buy" rating in a research report on Tuesday, April 8th.

Nutex Health Price Performance

NASDAQ:NUTX traded up $0.04 during mid-day trading on Friday, hitting $120.73. The company's stock had a trading volume of 57,988 shares, compared to its average volume of 61,639. The company has a market capitalization of $667.40 million, a price-to-earnings ratio of -12.86 and a beta of -0.10. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. Nutex Health Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $152.51. The stock has a fifty day moving average of $91.15 and a 200-day moving average of $56.76.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $11.21. The business had revenue of $81.30 million during the quarter, compared to analysts' expectations of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.